Objectives

After participating in this educational activity, attendees should be able to:
1. Understand the current indications for LifeVest in the setting of acute MI and low LVEF.
2. Analyze the latest evidence surrounding the use of LifeVest for acute MI indication; specifically the VEST trial.


 

Faculty

Amir Lotfi, MD
Associate Chief, Department of Cardiology
Baystate Health

Jose Antonio Rodriguez-Arciniega, MD
Cardiovascular Disease
Baystate Health

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.